A prescription-based rapid diagnostic test for detecting SARS-CoV-2 antigen in clinical settings. The test is authorized for distribution and clinical use by health providers.
Manufactured by
Wondfo USA Co., Ltd.
United States
Wondfo USA is a branch of Wondfo Biotech Co., Ltd. located in the United States. Wondfo USA distributes rapid drug testing kits as well as other POCT products, which are manufactured by its parent company. Headquartered in Guangzhou, China, Wondfo is a globally recognized fast-growing POCT manufacturer specialized in R&D, manufacture, and sales of rapid diagnostic tests and related medical devices for in vitro diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
OraSure Technologies Inc.
United States · 1 relevant product
Hangzhou Frenovo Biotech Co., Ltd
China · 3 relevant products
Biopanda Reagents
United Kingdom · 1 relevant product
83 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 34 relevant matches
OraSure Technologies Inc. · United States
The InteliSwab COVID-19 Rapid Test Rx is FDA-authorized for prescription home use. It uses samples self-collected from the lower nostrils and delivers results within 30 minutes with no instruments, batteries, smartphone or laboratory analysis needed.
Hangzhou Frenovo Biotech Co., Ltd · China
Rapid diagnostic test for detection of SARS-CoV-2 antigen. Provides quick identification of active COVID-19 infection for point-of-care testing.
Biopanda Reagents · United Kingdom
Lateral flow immunoassay for rapid detection of SARS-CoV-2 antigen in respiratory specimens. Provides quick results for point-of-care COVID-19 diagnosis in clinical and laboratory settings.
31 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products